148
Participants
Start Date
March 19, 2021
Primary Completion Date
December 7, 2022
Study Completion Date
December 7, 2022
Genetically-Informed RiskProfile
"* Participants will meet with a behavioral interventionist to receive their personalized genetically-informed RiskProfile intervention which incorporates smoking-related genetic risk propensity and phenotypic risk (cigarettes smoked per day) into a risk communication tool designed to activate behavior change, specifically, to increase the use of smoking cessation medications and promote smoking-related behavior change.~* This is a fully remote trial, with intervention delivered via video conferencing."
Brief Cessation Advice
"* Participants will meet with a behavioral interventionist to receive standardized brief advice to quit smoking and encouragement to use freely-available smoking cessation resources. Participants will receive their personalized RiskProfile after all data collection has been completed.~* This is a fully remote trial, with brief cessation advice delivered via video conferencing."
Washington University School of Medicine, St Louis
National Institute on Drug Abuse (NIDA)
NIH
Washington University School of Medicine
OTHER